Concepts (303)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Disease Outbreaks | 23 | 2022 | 1772 | 3.980 |
Why?
|
Leptospirosis | 5 | 2018 | 29 | 1.630 |
Why?
|
Floods | 3 | 2019 | 42 | 1.220 |
Why?
|
Antibodies, Viral | 15 | 2023 | 3176 | 1.220 |
Why?
|
Hemorrhagic Fever, Ebola | 5 | 2022 | 428 | 1.170 |
Why?
|
Fiji | 17 | 2021 | 47 | 1.040 |
Why?
|
Dengue | 8 | 2021 | 256 | 0.950 |
Why?
|
Typhoid Fever | 7 | 2020 | 197 | 0.870 |
Why?
|
Leptospira | 2 | 2018 | 11 | 0.810 |
Why?
|
Disaster Planning | 3 | 2019 | 548 | 0.780 |
Why?
|
Diarrhea | 3 | 2017 | 1347 | 0.760 |
Why?
|
Communicable Disease Control | 4 | 2016 | 857 | 0.760 |
Why?
|
Cyclonic Storms | 3 | 2019 | 119 | 0.730 |
Why?
|
Pacific Islands | 9 | 2018 | 50 | 0.730 |
Why?
|
Zoonoses | 2 | 2018 | 185 | 0.650 |
Why?
|
Rotavirus Infections | 2 | 2016 | 86 | 0.630 |
Why?
|
Seroepidemiologic Studies | 9 | 2022 | 402 | 0.630 |
Why?
|
Rotavirus | 2 | 2016 | 109 | 0.630 |
Why?
|
Thiamine Deficiency | 1 | 2018 | 43 | 0.620 |
Why?
|
Chromium | 1 | 2018 | 123 | 0.620 |
Why?
|
El Nino-Southern Oscillation | 1 | 2017 | 2 | 0.610 |
Why?
|
Staphylococcal Skin Infections | 1 | 2018 | 75 | 0.610 |
Why?
|
Thiamine | 1 | 2018 | 152 | 0.590 |
Why?
|
Antibodies, Bacterial | 4 | 2018 | 1470 | 0.570 |
Why?
|
Soft Tissue Infections | 1 | 2018 | 155 | 0.560 |
Why?
|
Rubella Syndrome, Congenital | 1 | 2016 | 12 | 0.560 |
Why?
|
Vitamin B Complex | 1 | 2018 | 288 | 0.540 |
Why?
|
Staphylococcal Infections | 2 | 2018 | 1400 | 0.500 |
Why?
|
Travel | 4 | 2021 | 788 | 0.490 |
Why?
|
Sentinel Surveillance | 1 | 2016 | 281 | 0.480 |
Why?
|
Tsunamis | 1 | 2014 | 59 | 0.470 |
Why?
|
Salmonella typhi | 6 | 2020 | 201 | 0.460 |
Why?
|
DNA, Bacterial | 1 | 2018 | 1467 | 0.460 |
Why?
|
Dengue Virus | 5 | 2021 | 204 | 0.450 |
Why?
|
Melanesia | 4 | 2016 | 18 | 0.440 |
Why?
|
Emergencies | 1 | 2019 | 1170 | 0.420 |
Why?
|
Public Health Practice | 1 | 2014 | 217 | 0.410 |
Why?
|
Plasmodium vivax | 1 | 2014 | 208 | 0.410 |
Why?
|
Malaria, Vivax | 1 | 2014 | 173 | 0.410 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 687 | 0.400 |
Why?
|
Epidemiologic Methods | 1 | 2016 | 1365 | 0.380 |
Why?
|
Health Care Rationing | 2 | 2013 | 437 | 0.380 |
Why?
|
Ross River virus | 2 | 2020 | 4 | 0.360 |
Why?
|
Community-Acquired Infections | 2 | 2018 | 464 | 0.360 |
Why?
|
Health Plan Implementation | 1 | 2013 | 351 | 0.360 |
Why?
|
International Cooperation | 2 | 2014 | 1421 | 0.360 |
Why?
|
Alphavirus Infections | 2 | 2020 | 17 | 0.360 |
Why?
|
Typhoid-Paratyphoid Vaccines | 3 | 2020 | 39 | 0.330 |
Why?
|
Pyomyositis | 1 | 2008 | 10 | 0.330 |
Why?
|
Pneumothorax | 1 | 2012 | 379 | 0.320 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3132 | 0.320 |
Why?
|
Climate Change | 3 | 2019 | 418 | 0.310 |
Why?
|
Cerebral Hemorrhage, Traumatic | 1 | 2007 | 20 | 0.300 |
Why?
|
Methicillin Resistance | 1 | 2008 | 198 | 0.300 |
Why?
|
Health Promotion | 3 | 2017 | 2205 | 0.300 |
Why?
|
Head Injuries, Penetrating | 1 | 2007 | 28 | 0.300 |
Why?
|
United Arab Emirates | 2 | 2018 | 42 | 0.290 |
Why?
|
Compartment Syndromes | 1 | 2008 | 153 | 0.280 |
Why?
|
Patient Acceptance of Health Care | 2 | 2022 | 3023 | 0.280 |
Why?
|
Young Adult | 21 | 2022 | 56436 | 0.270 |
Why?
|
Nucleocapsid | 2 | 2023 | 59 | 0.270 |
Why?
|
Primary Prevention | 1 | 2013 | 1167 | 0.270 |
Why?
|
Immunoglobulin G | 7 | 2022 | 4559 | 0.270 |
Why?
|
Malaria, Falciparum | 1 | 2014 | 1077 | 0.260 |
Why?
|
Humans | 72 | 2023 | 744220 | 0.260 |
Why?
|
Population Surveillance | 7 | 2020 | 2616 | 0.250 |
Why?
|
Guillain-Barre Syndrome | 2 | 2016 | 123 | 0.250 |
Why?
|
Adolescent | 23 | 2022 | 85759 | 0.250 |
Why?
|
Micronesia | 4 | 2017 | 43 | 0.250 |
Why?
|
Infant | 16 | 2021 | 35129 | 0.240 |
Why?
|
Plasmodium falciparum | 1 | 2014 | 1732 | 0.240 |
Why?
|
Antibodies, Neutralizing | 6 | 2023 | 1978 | 0.240 |
Why?
|
Dominican Republic | 1 | 2023 | 76 | 0.230 |
Why?
|
Family Characteristics | 2 | 2019 | 1000 | 0.220 |
Why?
|
Public Health | 4 | 2020 | 2603 | 0.220 |
Why?
|
Cross Reactions | 2 | 2022 | 841 | 0.220 |
Why?
|
Polynesia | 3 | 2018 | 13 | 0.220 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2020 | 3871 | 0.210 |
Why?
|
Rain | 2 | 2018 | 61 | 0.200 |
Why?
|
World Health Organization | 4 | 2015 | 1318 | 0.200 |
Why?
|
Sanitation | 3 | 2017 | 93 | 0.200 |
Why?
|
Child, Preschool | 15 | 2021 | 40992 | 0.200 |
Why?
|
Seasons | 5 | 2021 | 1494 | 0.200 |
Why?
|
Flavivirus Infections | 1 | 2021 | 16 | 0.200 |
Why?
|
Malaria | 1 | 2011 | 1239 | 0.200 |
Why?
|
Receptors, Fc | 2 | 2022 | 541 | 0.200 |
Why?
|
Wounds, Gunshot | 1 | 2007 | 563 | 0.200 |
Why?
|
Disasters | 2 | 2019 | 511 | 0.190 |
Why?
|
Infant, Newborn | 9 | 2021 | 25618 | 0.180 |
Why?
|
Immunity, Humoral | 2 | 2021 | 598 | 0.180 |
Why?
|
Staphylococcus aureus | 1 | 2008 | 1451 | 0.180 |
Why?
|
Adult | 25 | 2022 | 214035 | 0.170 |
Why?
|
Congo | 1 | 2019 | 13 | 0.170 |
Why?
|
Vaccination | 5 | 2022 | 3278 | 0.170 |
Why?
|
Obesity | 1 | 2021 | 12742 | 0.170 |
Why?
|
Chikungunya virus | 1 | 2019 | 50 | 0.170 |
Why?
|
Space Flight | 1 | 2021 | 188 | 0.170 |
Why?
|
Male | 29 | 2022 | 350027 | 0.170 |
Why?
|
Emergency Service, Hospital | 1 | 2018 | 7659 | 0.160 |
Why?
|
Immunoglobulin M | 2 | 2021 | 1538 | 0.160 |
Why?
|
Phylogeny | 5 | 2019 | 2803 | 0.160 |
Why?
|
Female | 30 | 2022 | 380197 | 0.160 |
Why?
|
Child | 18 | 2021 | 77679 | 0.160 |
Why?
|
Africa, Western | 2 | 2015 | 154 | 0.160 |
Why?
|
Students, Public Health | 1 | 2017 | 6 | 0.160 |
Why?
|
Rehydration Solutions | 1 | 2018 | 47 | 0.160 |
Why?
|
Immunoassay | 1 | 2021 | 752 | 0.160 |
Why?
|
Middle Aged | 21 | 2022 | 213367 | 0.150 |
Why?
|
Risk Assessment | 3 | 2018 | 23337 | 0.150 |
Why?
|
Droughts | 1 | 2017 | 28 | 0.150 |
Why?
|
Health | 1 | 2020 | 394 | 0.150 |
Why?
|
Environmental Health | 1 | 2019 | 278 | 0.150 |
Why?
|
Hygiene | 1 | 2017 | 98 | 0.140 |
Why?
|
Risk Factors | 8 | 2021 | 72280 | 0.140 |
Why?
|
Serologic Tests | 1 | 2018 | 374 | 0.140 |
Why?
|
Salmonella Infections | 1 | 2017 | 173 | 0.140 |
Why?
|
Social Control, Formal | 2 | 2013 | 110 | 0.140 |
Why?
|
Cattle Diseases | 1 | 2016 | 53 | 0.140 |
Why?
|
Sodium Chloride | 1 | 2018 | 625 | 0.130 |
Why?
|
Fever | 1 | 2023 | 1614 | 0.130 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 738 | 0.130 |
Why?
|
Epidemiology | 1 | 2017 | 287 | 0.120 |
Why?
|
Incidence | 6 | 2020 | 20945 | 0.120 |
Why?
|
Trust | 1 | 2019 | 505 | 0.120 |
Why?
|
Kinetics | 1 | 2022 | 6474 | 0.120 |
Why?
|
Leprosy | 1 | 2014 | 127 | 0.120 |
Why?
|
Age Factors | 3 | 2021 | 18367 | 0.120 |
Why?
|
Cattle | 2 | 2020 | 3922 | 0.120 |
Why?
|
Papua New Guinea | 1 | 2013 | 42 | 0.120 |
Why?
|
Fluid Therapy | 1 | 2018 | 593 | 0.120 |
Why?
|
Pandemics | 7 | 2021 | 8387 | 0.120 |
Why?
|
Phosphoproteins | 1 | 2022 | 2440 | 0.110 |
Why?
|
Epidemics | 2 | 2021 | 523 | 0.110 |
Why?
|
Lung | 1 | 2012 | 9852 | 0.110 |
Why?
|
Case-Control Studies | 4 | 2018 | 21752 | 0.110 |
Why?
|
Polymerase Chain Reaction | 2 | 2022 | 6172 | 0.110 |
Why?
|
Communicable Diseases | 1 | 2021 | 880 | 0.110 |
Why?
|
Capsid Proteins | 1 | 2016 | 479 | 0.110 |
Why?
|
Disease Transmission, Infectious | 1 | 2018 | 547 | 0.110 |
Why?
|
Cross-Sectional Studies | 6 | 2022 | 25043 | 0.110 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3239 | 0.100 |
Why?
|
Gastroenteritis | 1 | 2014 | 245 | 0.100 |
Why?
|
Antigens, Viral | 1 | 2016 | 1035 | 0.100 |
Why?
|
Sports | 1 | 2018 | 688 | 0.100 |
Why?
|
Altitude Sickness | 1 | 2012 | 92 | 0.100 |
Why?
|
Maternal Exposure | 1 | 2018 | 961 | 0.100 |
Why?
|
Ecosystem | 1 | 2016 | 474 | 0.100 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2018 | 979 | 0.100 |
Why?
|
Preventive Health Services | 2 | 2013 | 575 | 0.100 |
Why?
|
Democratic Republic of the Congo | 2 | 2022 | 88 | 0.100 |
Why?
|
Polysaccharides, Bacterial | 1 | 2014 | 578 | 0.100 |
Why?
|
Logistic Models | 4 | 2022 | 13409 | 0.100 |
Why?
|
Social Behavior | 1 | 2017 | 1127 | 0.100 |
Why?
|
Sensitivity and Specificity | 3 | 2021 | 14726 | 0.100 |
Why?
|
Eating | 1 | 2017 | 1538 | 0.090 |
Why?
|
Respiratory Tract Infections | 1 | 2018 | 961 | 0.090 |
Why?
|
Information Dissemination | 1 | 2019 | 1100 | 0.090 |
Why?
|
Health Behavior | 1 | 2022 | 2636 | 0.090 |
Why?
|
Commerce | 1 | 2015 | 592 | 0.090 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2012 | 367 | 0.090 |
Why?
|
Environment | 1 | 2016 | 1124 | 0.090 |
Why?
|
Aedes | 3 | 2014 | 100 | 0.090 |
Why?
|
Multiple Trauma | 1 | 2012 | 367 | 0.080 |
Why?
|
Sex Factors | 2 | 2022 | 10396 | 0.080 |
Why?
|
Vasodilator Agents | 1 | 2012 | 977 | 0.080 |
Why?
|
Models, Theoretical | 2 | 2018 | 3591 | 0.080 |
Why?
|
Environmental Exposure | 2 | 2019 | 4236 | 0.070 |
Why?
|
Child Development | 1 | 2018 | 2223 | 0.070 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2018 | 2026 | 0.070 |
Why?
|
Viral Proteins | 1 | 2014 | 1900 | 0.070 |
Why?
|
Hospitalization | 2 | 2018 | 10262 | 0.070 |
Why?
|
Multivariate Analysis | 2 | 2017 | 12244 | 0.070 |
Why?
|
Accidents, Traffic | 1 | 2012 | 819 | 0.070 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2018 | 2408 | 0.070 |
Why?
|
Forearm | 1 | 2008 | 409 | 0.070 |
Why?
|
Acute Disease | 2 | 2018 | 7148 | 0.070 |
Why?
|
Prevalence | 3 | 2020 | 15226 | 0.070 |
Why?
|
Aged | 11 | 2022 | 163253 | 0.070 |
Why?
|
Influenza Vaccines | 1 | 2013 | 738 | 0.070 |
Why?
|
Socioeconomic Factors | 2 | 2017 | 7784 | 0.070 |
Why?
|
Radiography, Thoracic | 1 | 2012 | 1265 | 0.060 |
Why?
|
Aged, 80 and over | 5 | 2018 | 57768 | 0.060 |
Why?
|
Australia | 2 | 2021 | 1169 | 0.060 |
Why?
|
Communication | 1 | 2019 | 3749 | 0.060 |
Why?
|
Prospective Studies | 3 | 2022 | 53280 | 0.060 |
Why?
|
Retrospective Studies | 7 | 2021 | 77426 | 0.060 |
Why?
|
Anti-Bacterial Agents | 3 | 2018 | 7179 | 0.060 |
Why?
|
Antimalarials | 1 | 2011 | 907 | 0.060 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2019 | 3923 | 0.060 |
Why?
|
Body Mass Index | 1 | 2021 | 12718 | 0.060 |
Why?
|
Disease Management | 1 | 2014 | 2458 | 0.060 |
Why?
|
History, 21st Century | 2 | 2020 | 1534 | 0.060 |
Why?
|
Models, Statistical | 1 | 2018 | 5102 | 0.060 |
Why?
|
Rural Population | 3 | 2018 | 2210 | 0.050 |
Why?
|
Animals | 10 | 2022 | 168788 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5319 | 0.050 |
Why?
|
Coronavirus OC43, Human | 1 | 2021 | 18 | 0.050 |
Why?
|
Time Factors | 3 | 2022 | 40063 | 0.050 |
Why?
|
Hypertension, Pulmonary | 1 | 2012 | 1536 | 0.050 |
Why?
|
Influenza, Human | 1 | 2013 | 1480 | 0.050 |
Why?
|
Flavivirus | 1 | 2021 | 20 | 0.050 |
Why?
|
Samoa | 1 | 2020 | 6 | 0.050 |
Why?
|
Sequence Analysis, DNA | 3 | 2019 | 4803 | 0.050 |
Why?
|
Culicidae | 1 | 2021 | 105 | 0.050 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2023 | 401 | 0.050 |
Why?
|
Pregnancy | 4 | 2020 | 29142 | 0.050 |
Why?
|
Marsupialia | 1 | 2020 | 26 | 0.050 |
Why?
|
Asymptomatic Infections | 1 | 2021 | 128 | 0.050 |
Why?
|
Goats | 1 | 2020 | 172 | 0.050 |
Why?
|
Odds Ratio | 3 | 2018 | 9849 | 0.040 |
Why?
|
Immunoglobulin Class Switching | 1 | 2021 | 291 | 0.040 |
Why?
|
Neutralization Tests | 1 | 2022 | 758 | 0.040 |
Why?
|
Emergency Medical Services | 1 | 2011 | 1916 | 0.040 |
Why?
|
Vaccines, Synthetic | 1 | 2022 | 634 | 0.040 |
Why?
|
Horses | 1 | 2020 | 304 | 0.040 |
Why?
|
Livestock | 1 | 2018 | 19 | 0.040 |
Why?
|
Cluster Analysis | 2 | 2018 | 2715 | 0.040 |
Why?
|
Vaccines, Conjugate | 1 | 2020 | 333 | 0.040 |
Why?
|
Ethiopia | 1 | 2020 | 495 | 0.040 |
Why?
|
Animal Husbandry | 1 | 2018 | 66 | 0.040 |
Why?
|
Immunity, Herd | 1 | 2018 | 44 | 0.040 |
Why?
|
Animals, Domestic | 1 | 2017 | 56 | 0.040 |
Why?
|
Environmental Microbiology | 1 | 2018 | 46 | 0.040 |
Why?
|
Government Programs | 1 | 2020 | 275 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2021 | 992 | 0.040 |
Why?
|
Carrier State | 1 | 2021 | 518 | 0.040 |
Why?
|
Agriculture | 1 | 2018 | 190 | 0.040 |
Why?
|
Poverty | 2 | 2018 | 2660 | 0.040 |
Why?
|
Radiography | 1 | 2007 | 7022 | 0.030 |
Why?
|
Workplace | 1 | 2022 | 836 | 0.030 |
Why?
|
Viral Envelope Proteins | 1 | 2019 | 635 | 0.030 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2021 | 611 | 0.030 |
Why?
|
Peptides, Cyclic | 1 | 2018 | 401 | 0.030 |
Why?
|
Phylogeography | 1 | 2015 | 82 | 0.030 |
Why?
|
Contact Tracing | 1 | 2017 | 273 | 0.030 |
Why?
|
Macaca mulatta | 1 | 2022 | 2378 | 0.030 |
Why?
|
Viral Vaccines | 1 | 2021 | 636 | 0.030 |
Why?
|
Ownership | 1 | 2017 | 332 | 0.030 |
Why?
|
Infectious Disease Incubation Period | 1 | 2014 | 17 | 0.030 |
Why?
|
Dogs | 1 | 2020 | 3913 | 0.030 |
Why?
|
New Caledonia | 1 | 2014 | 3 | 0.030 |
Why?
|
Immunity | 1 | 2021 | 1012 | 0.030 |
Why?
|
Mycobacterium leprae | 1 | 2014 | 97 | 0.030 |
Why?
|
Disease Vectors | 1 | 2014 | 60 | 0.030 |
Why?
|
High-Throughput Screening Assays | 1 | 2020 | 945 | 0.030 |
Why?
|
Salmonella enterica | 1 | 2014 | 75 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3270 | 0.030 |
Why?
|
Population Density | 1 | 2014 | 196 | 0.030 |
Why?
|
Self Efficacy | 1 | 2017 | 616 | 0.030 |
Why?
|
Congenital Abnormalities | 1 | 2018 | 707 | 0.030 |
Why?
|
Neurologic Examination | 1 | 2016 | 931 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2018 | 2272 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2008 | 12961 | 0.030 |
Why?
|
Viral Nonstructural Proteins | 1 | 2014 | 241 | 0.030 |
Why?
|
Host-Pathogen Interactions | 1 | 2022 | 1477 | 0.030 |
Why?
|
Mountaineering | 1 | 2012 | 45 | 0.030 |
Why?
|
Acetazolamide | 1 | 2012 | 100 | 0.030 |
Why?
|
Communicable Diseases, Emerging | 1 | 2014 | 157 | 0.030 |
Why?
|
Ciprofloxacin | 1 | 2014 | 315 | 0.030 |
Why?
|
Demography | 1 | 2017 | 1656 | 0.030 |
Why?
|
Nifedipine | 1 | 2012 | 226 | 0.030 |
Why?
|
Sex Distribution | 1 | 2017 | 2297 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2018 | 1462 | 0.030 |
Why?
|
Molecular Epidemiology | 1 | 2014 | 468 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15538 | 0.030 |
Why?
|
Ebolavirus | 1 | 2014 | 263 | 0.030 |
Why?
|
Nepal | 1 | 2012 | 295 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2015 | 18116 | 0.020 |
Why?
|
Age Distribution | 1 | 2017 | 2903 | 0.020 |
Why?
|
Survivors | 1 | 2021 | 2291 | 0.020 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2015 | 567 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2018 | 2309 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 5076 | 0.020 |
Why?
|
Urban Population | 1 | 2018 | 2021 | 0.020 |
Why?
|
Genome, Bacterial | 1 | 2015 | 760 | 0.020 |
Why?
|
Quinolines | 1 | 2015 | 730 | 0.020 |
Why?
|
Sulfones | 1 | 2012 | 437 | 0.020 |
Why?
|
Interpersonal Relations | 1 | 2017 | 1424 | 0.020 |
Why?
|
Swine | 1 | 2020 | 5940 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2014 | 764 | 0.020 |
Why?
|
Protein Binding | 1 | 2022 | 9392 | 0.020 |
Why?
|
Purines | 1 | 2012 | 594 | 0.020 |
Why?
|
Program Evaluation | 1 | 2017 | 2486 | 0.020 |
Why?
|
Emergency Treatment | 1 | 2012 | 517 | 0.020 |
Why?
|
Cohort Studies | 2 | 2021 | 40559 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2014 | 2970 | 0.020 |
Why?
|
Survival Analysis | 1 | 2020 | 10250 | 0.020 |
Why?
|
United States | 3 | 2022 | 69867 | 0.020 |
Why?
|
Evolution, Molecular | 1 | 2014 | 1939 | 0.020 |
Why?
|
RNA, Viral | 1 | 2014 | 2902 | 0.020 |
Why?
|
Dexamethasone | 1 | 2012 | 1948 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2012 | 63119 | 0.020 |
Why?
|
Disease Progression | 1 | 2021 | 13280 | 0.020 |
Why?
|
Pilot Projects | 1 | 2017 | 8321 | 0.020 |
Why?
|
Curriculum | 1 | 2017 | 3604 | 0.020 |
Why?
|
Rats | 1 | 2020 | 24273 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2021 | 10182 | 0.010 |
Why?
|
Mortality | 1 | 2014 | 2864 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2020 | 19907 | 0.010 |
Why?
|
Piperazines | 1 | 2012 | 2491 | 0.010 |
Why?
|
Genotype | 1 | 2014 | 12956 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2014 | 7281 | 0.010 |
Why?
|
Mice | 1 | 2020 | 81178 | 0.010 |
Why?
|
Concepts
(303)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(59)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_